Johnson & Johnson Posts Solid Fourth-Quarter Earnings With Broad Support From All Divisions
We don’t expect any major changes to the stock’s fair value estimate of $164 .
Stay updated with breaking news from Johnson Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We don’t expect any major changes to the stock’s fair value estimate of $164 .
07.12.2022 - Johnson & Johnson (NYSE: JNJ) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman Elect of the Board and Chief Executive Officer will ...
14.09.2022 - Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock. “The last few years have demonstrated the resilience of Johnson & Johnson. With continued ...
13.09.2022 - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica ...
09.08.2022 - Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, ...